9.1 C
Saturday, April 1, 2023

Yield10 Bioscience, Inc. (YTEN) Q4 2022 Earnings Call Transcript

Must read

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2022 Earnings Conference Call March 14, 2023 4:30 PM ET

Company Participants

Lynne Brum – Vice President of Planning and Corporate Communications

Oliver Peoples – President and Chief Executive Officer

Kristi Snell – Vice President of Research and Chief Science Officer

Chuck Haaser – Chief Accounting Officer

Conference Call Participants

Ben Klieve – Lake Street Capital Markets

Anthony Vendetti – Maxim Group

Sameer Joshi – H.C. Wainwright


Greeting and welcome to the Fourth Quarter 2022 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen-only mode. The presenters will address questions from the analysts today. [Operator Instructions] As a reminder, this conference call is being recorded.

I would now like to turn the conference call over to your host, Yield10 Vice President of Planning and Corporate Communications, Lynne Brum.

Lynne Brum

Thank you, Doug, and good afternoon, everyone. Welcome to the Yield10 Bioscience fourth quarter and full year 2022 conference call. Joining me on the call today are President and CEO, Dr. Oliver Peoples; Vice President of Research and Chief Science Officer, Dr. Kristi Snell; and Chief Accounting Officer, Chuck Haaser. Earlier this afternoon, Yield10 issued our fourth quarter 2022 financial results. This press release as well as slides that accompany today’s presentation are available on the Investor Relations Events section of our website at yield10bio.com.

Let’s turn to Slide 2. Please note that as part of our discussion today management will be making forward-looking statements. These statements are not guarantees of future performance, and therefore, you should not place undue reliance on them. Investors are also cautioned that statements are not strictly historical constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These risks

Source link

- Advertisement -

More articles

Leave a Reply

- Advertisement -

Latest article

%d bloggers like this: